Home > Boards > US OTC > Medical - Healthcare > InVivo Therapeutics Holdings Corp (NVIV)

To the Board of Directors

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DDobserver Member Profile
 
Followed By 6
Posts 380
Boards Moderated 0
Alias Born 06/24/14
160x600 placeholder
InVivo Therapeutics gibt Vertagung der Hauptversammlung bekannt Business Wire - 6/14/2019 1:21:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 8:06:21 AM
InVivo Therapeutics Announces Adjournment of Annual Meeting Business Wire - 6/14/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2019 7:51:21 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:10:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:07:49 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/30/2019 6:01:28 AM
InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal C... Business Wire - 5/29/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/22/2019 5:56:59 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 5/17/2019 4:37:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 8:03:06 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/25/2019 5:22:49 PM
InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal... Business Wire - 4/17/2019 8:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/15/2019 5:14:37 PM
InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update Business Wire - 4/1/2019 8:15:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/1/2019 8:10:25 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 8:04:59 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/20/2019 6:31:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/20/2019 4:13:26 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 1:48:59 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 1:46:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2019 4:43:10 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 1/16/2019 4:41:27 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 1/14/2019 5:31:18 PM
DDobserver   Wednesday, 10/17/18 08:17:05 AM
Re: None
Post # of 6120 
To the Board of Directors

Thank you for the updates with the many releases of information. Now, can/will you communicate the methodology to meet the objectives.

It is a great thought that the doctor will try to achieve certain objectives of approval from the FDA. It is a great thought that we will join forces with another research company.

If approvals from the FDA come to fruition what will the next step be?
What is the expected timelines?



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist